NDC 0006-0573
CRIXIVAN
Indinavir Sulfate
CRIXIVAN is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Corp.. The primary component is Indinavir Sulfate.
| Product ID | 0006-0573_2f1ee2da-8e76-4c4e-8006-285449f74f1b |
| NDC | 0006-0573 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CRIXIVAN |
| Generic Name | Indinavir Sulfate |
| Dosage Form | Capsule |
| Route of Administration | ORAL |
| Marketing Start Date | 1996-03-13 |
| Marketing Category | NDA / NDA |
| Application Number | NDA020685 |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | INDINAVIR SULFATE |
| Active Ingredient Strength | 400 mg/1 |
| Pharm Classes | HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
Packaging
NDC 0006-0573-62
180 CAPSULE in 1 BOTTLE (0006-0573-62)
| Marketing Start Date | 1996-03-13 |
| NDC Exclude Flag | N |
| Sample Package? | N |
NDC SPL Data Element Entries
NDC 0006-0573-42 [00006057342]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-03-13 |
| Marketing End Date | 2012-06-08 |
NDC 0006-0573-62 [00006057362]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-03-13 |
NDC 0006-0573-40 [00006057340]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1996-03-13 |
| Marketing End Date | 2014-02-28 |
NDC 0006-0573-18 [00006057318]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-03-13 |
| Marketing End Date | 2012-06-08 |
NDC 0006-0573-01 [00006057301]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 1996-03-13 |
| Marketing End Date | 2012-06-08 |
NDC 0006-0573-54 [00006057354]
CRIXIVAN CAPSULE
| Marketing Category | NDA |
| Application Number | NDA020685 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 1996-03-13 |
| Marketing End Date | 2014-02-28 |
Drug Details
Active Ingredients
| Ingredient | Strength |
|---|---|
| INDINAVIR SULFATE | 400 mg/1 |
OpenFDA Data
| SPL SET ID: | e19405d9-d9a1-4072-5b9e-40cd3ae4bf1f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
Pharmacological Class
- HIV Protease Inhibitors [MoA]
- Protease Inhibitor [EPC]
- Cytochrome P450 3A4 Inhibitors [MoA]
NDC Crossover Matching brand name "CRIXIVAN" or generic name "Indinavir Sulfate"
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0006-0571 | CRIXIVAN | indinavir sulfate |
| 0006-0573 | CRIXIVAN | indinavir sulfate |
| 21695-366 | CRIXIVAN | indinavir sulfate |
| 53808-0661 | CRIXIVAN | indinavir sulfate |
Trademark Results [CRIXIVAN]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 CRIXIVAN 74194790 1933374 Live/Registered |
MERCK SHARP & DOHME CORP. 1991-08-15 |
 CRIXIVAN 74000084 not registered Dead/Abandoned |
MERCK & CO., INC. 1989-11-16 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.